Teva Pharmaceuticals

Teva Pharmaceutical Industries Ltd. is a global leader in the pharmaceutical industry, recognized as the world's largest generic drug manufacturer. The company's origins date back to 1901 in Jerusalem, where it began as a small wholesale drug distribution business named Salomon, Levin, and Elstein Ltd. Over the decades, the company evolved through significant mergers, most notably the 1976 consolidation of Teva, Assia, and Zori, which formed the modern-day corporation. It formally adopted the name Teva, which means 'nature' in Hebrew, reflecting its commitment to health and local manufacturing.

Today, Teva operates an extensive global manufacturing network with over 50 production facilities located in 33 countries, including Israel, the United States, Germany, Hungary, India, and Canada. This diverse footprint allows the company to produce a vast portfolio of approximately 3,500 products ranging from generic capsules to innovative specialty treatments for respiratory and neurological conditions.

As a publicly traded company listed on both the Tel Aviv Stock Exchange (TASE) and the New York Stock Exchange (NYSE), Teva is owned by a broad base of international institutional and individual investors. Major stakeholders typically include global asset management firms such as BlackRock, Vanguard, and FMR LLC. While its roots are deeply embedded in Israel, it functions as a multinational entity with a global governance structure and headquarters in Tel Aviv.